User profiles for Perrine Janiaud

Perrine Janiaud

Department of Clinical Research, University Hospital Basel
Verified email at usb.ch
Cited by 2005

[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

C Axfors, AM Schmitt, P Janiaud, J Van't Hooft… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

[HTML][HTML] Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: a systematic review and meta-analysis

P Janiaud, C Axfors, AM Schmitt, V Gloy, F Ebrahimi… - Jama, 2021 - jamanetwork.com
… I read with interest the systematic review by Janiaud et al detailing clinical outcomes after
therapeutic intervention with COVID19 convalescent plasma (CCP) [1]. The topic has become …

Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials

…, AT Heravi, C Schönenberger, P Janiaud… - The Lancet …, 2023 - thelancet.com
Background Interpretation of the evidence from randomised controlled trials (RCTs) of
remdesivir in patients treated in hospital for COVID-19 is conflicting. We aimed to assess the …

[HTML][HTML] Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?

R Dal-Ré, P Janiaud, JPA Ioannidis - BMC medicine, 2018 - Springer
Introduction Pragmatic randomized controlled trials (RCTs) mimic usual clinical practice and
they are critical to inform decision-making by patients, clinicians and policy-makers in real-…

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and …

F Naudet, C Sakarovitch, P Janiaud, I Cristea, D Fanelli… - Bmj, 2018 - bmj.com
Objectives To explore the effectiveness of data sharing by randomized controlled trials (RCTs)
in journals with a full data sharing policy and to describe potential difficulties encountered …

New clinical trial designs in the era of precision medicine: an overview of definitions, strengths, weaknesses, and current use in oncology

P Janiaud, S Serghiou, JPA Ioannidis - Cancer Treatment Reviews, 2019 - Elsevier
With expanding knowledge in tumor biology and biomarkers, oncology therapies are
increasingly moving away from the “one-size-fits-all” rationale onto biomarker-driven therapies …

[HTML][HTML] Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical …

C Axfors, P Janiaud, AM Schmitt, J van't Hooft… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only for a …

Calibrating the scientific ecosystem through meta-research

TE Hardwicke, S Serghiou, P Janiaud… - Annual Review of …, 2020 - annualreviews.org
While some scientists study insects, molecules, brains, or clouds, other scientists study
science itself. Meta-research, or research-on-research, is a burgeoning discipline that …

Challenges and lessons learned from COVID-19 trials: should we be doing clinical trials differently?

P Janiaud, LG Hemkens, JPA Ioannidis - Canadian Journal of Cardiology, 2021 - Elsevier
The COVID-19 crisis led to a flurry of clinical trials activity. The COVID-evidence database
shows 2814 COVID-19 randomized trials registered as of February 16, 2021. Most were small (…

[HTML][HTML] The worldwide clinical trial research response to the COVID-19 pandemic-the first 100 days

P Janiaud, C Axfors, J Van't Hooft, R Saccilotto… - …, 2020 - ncbi.nlm.nih.gov
Background: Never before have clinical trials drawn as much public attention as those
testing interventions for COVID-19. We aimed to describe the worldwide COVID-19 clinical …